California Governor's record of blocking health care reform criticized

23 July 2006

In the USA, California nurses and other labor groups have sharply criticized Governor Arnold Schwarzenegger's call for a health care summit on July 24 at the University of California Los Angeles as an election year ploy that belies a blocking of genuine health care reform.

"Arnold Schwarzenegger has opposed every health care reform he's seen," said Art Pulaski, executive secretary-treasurer of the California Labor Federation. "I find it hard to believe he's had a change of heart three months before the election. The governor has even failed on his own promise to expand health coverage for children," Mr Pulaski noted.

California Nurses Association Executive Director Rose Ann DeMoro accused Gov Schwarzenegger of "rhetorical pandering while offering empty solutions that abandon millions of Californians."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight